EX-99.1 3 j9710_ex99d1.htm EX-99.1

EXHIBIT 99.1

 

@coherent

PRESS RELEASE

 

Editorial Contact:

For Release:

Leen Simonet

IMMEDIATE

(408) 764-4161

April 22, 2003

 

No. 823

 

 

Coherent, Inc. Reports Second Quarter Results

 

Coherent, Inc. (Santa Clara, CA) (NASDAQ:COHR) today announced financial results for its second fiscal quarter ended March 29, 2003, posting sales of $103.5 million and net income of $1.9 million ($0.07 per diluted share). These earnings include a one-time gain of $2.0 million ($0.07 per diluted share) after-tax and net of minority interest representing a $4.4 million settlement fee received by our Lambda Physik AG subsidiary related to the cancellation of a customer contract dating back to the fourth quarter of fiscal 2001.  This gain was offset by a goodwill impairment charge of $1.8 million ($0.06 per diluted share) net of minority interest related to Lambda Physik’s lithography business.  Net income for the quarter of $0.06 per diluted share, excluding the above-mentioned items, was negatively impacted by a higher than anticipated inventory reserve requirement at Lambda Physik totaling $2.7 million ($1.2 million after-tax and net of minority interest ($0.04 per diluted share)) also necessitated by a lower forecasted outlook in the lithography business.

 

Orders received during the three months ended March 29, 2003 of $103.0 million represent a 12% increase over the like prior year period and a 9% increase to orders received in the immediately preceding quarter.  Backlog of $116.1 million at March 29, 2003, compares to a backlog of $116.6 million at December 28, 2002.

 

Sales and net income for the period compared to sales for the corresponding prior year period of $98.6 million, and net income of $3.0 million ($0.10 per diluted share), which included a $1.0 million ($0.03 per diluted share) after-tax gain on the sale of real estate.  In comparison, the immediately preceding quarter’s results were $102.0 million in sales, and a net loss of $20.5 million ($0.70 per share inclusive of restructuring and other charges).  The immediately preceding period’s net income, excluding restructuring and other charges, was $3.0 million ($0.10 per diluted share).

 

Year-to-date sales of $205.5 million and net loss of $18.6 million ($0.64 per diluted share) compared to the like prior year period sales of  $195.3 million and net income of $5.7 million ($0.20 per diluted share).  Net income before impairment, restructuring and other charges and special gains of $4.7 million ($0.16 per diluted share) compares to the prior year period net income before impairment, restructuring and other charges and special gains of $4.1 million ($0.14 per diluted share). Orders received for the six month period ended March 29, 2003 were $197.3 million, representing a 9% increase over orders received in the same period last year.

 

Electro-Optics segment sales of $79.3 million for the three months ended March 29, 2003 were 3% higher than sales during the comparable prior year period and 2% higher than the three months ended December 28, 2002.  Incoming orders of $83.7 million represent a 14% improvement over the same second fiscal quarter of 2002 and an increase of 5% from orders received in the immediately preceding quarter.  Sales and incoming orders for the six months ended March 29, 2003 were $157.2 million and $163.7 million, 4% and 9% higher, respectively, than during the same period a year ago.

 

Lambda Physik segment sales of $24.2 million for the three months ended March 29, 2003 represent an increase of 11% from the corresponding prior year period and a slight increase from the immediately preceding quarter.  Incoming orders of $19.3 million for the second quarter of fiscal 2003 were 2% higher than the second fiscal quarter of 2002, and represent a 35% improvement in orders from the immediately preceding first fiscal quarter of 2003.  Sales and incoming orders for the six months ended March 29, 2003 were $48.3 million and $33.6 million, respectively, and were 9% and 8% higher than the same period last year.

 



 

Subsequent to the quarter ended March 29, 2003, Coherent completed its previously announced acquisition of Positive Light, Inc. (PLI), a leading designer and manufacturer of advanced solid-state lasers for the scientific and industrial markets.  Coherent’s purchase price of approximately $43 million takes into account both PLI’s earnings and growth potential, particularly after the existing PLI distributor agreement with another laser company expires on December 31, 2003.

 

John Ambroseo, Coherent’s President and Chief Executive Officer commented, “We are encouraged by strengthening in certain end markets.  Our recent orders combined with our acquisition of Positive Light, Inc. should enable Coherent to achieve modest revenue growth during the second half of the fiscal year. And, as always, we remain committed to profitable growth and cash generation from ongoing operations.”

 

Ambroseo continued, “Today in a separate press release, Coherent announced it will make a tender offer to the shareholders of Lambda Physik AG for the 39.62% (5,250,000 shares) of the outstanding Lambda shares that Coherent does not already own.  We will offer Euro 9.25 (approximately $10.00) cash for each ordinary share of Lambda.   The acquisition of the remaining Lambda shares will allow us to cross leverage technologies providing our customers with even more enabling products, drive supply chain synergies, and reduce SG&A through the elimination of the added costs of operating two separate public companies.”

 

The Company’s conference call scheduled for 1:30 p.m. PST today will include discussions relative to the current quarter results and some comments regarding forward looking guidance on future operating performance.

 

Summarized statement of operations information is as follows (unaudited, in thousands, except per share data):

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

Mar. 29, 2003

 

Dec. 28, 2002

 

Mar. 30, 2002

 

Mar. 29, 2003

 

Mar. 30, 2002

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

103,512

 

$

102,030

 

$

98,649

 

$

205,542

 

$

195,268

 

Cost of sales (A)

 

62,521

 

61,587

 

58,657

 

124,108

 

113,256

 

Gross profit

 

40,991

 

40,443

 

39,992

 

81,434

 

82,012

 

Research and development

 

12,261

 

11,672

 

13,616

 

23,933

 

27,544

 

Intangibles amortization

 

947

 

835

 

898

 

1,782

 

1,806

 

Goodwill impairment (B)

 

2,358

 

 

 

 

 

2,358

 

 

 

Restructuring and other charges (C)

 

405

 

20,059

 

 

 

20,464

 

 

 

Selling, general and administrative

 

25,923

 

23,664

 

23,306

 

49,587

 

46,025

 

Total operating expenses

 

41,894

 

56,230

 

37,820

 

98,124

 

75,375

 

Income (loss) from operations

 

(903

)

(15,787

)

2,172

 

(16,690

)

6,637

 

Other income (expense), net (D) (E) (F)

 

4,795

 

(9,769

)

2,755

 

(4,974

)

2,537

 

Income (loss) before income taxes andminority interest

 

3,892

 

(25,556

)

4,927

 

(21,664

)

9,174

 

Provision (benefit) for taxes

 

2,033

 

(5,350

)

1,684

 

(3,317

)

3,056

 

Income (loss) before minority interest

 

1,859

 

(20,206

)

3,243

 

(18,347

)

6,118

 

Minority interest

 

68

 

(277

)

(236

)

(209

)

(381

)

Net income (loss)

 

$

1,927

 

$

(20,483

)

$

3,007

 

$

(18,556

)

$

5,737

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share, diluted

 

$

0.07

 

$

(0.70

)

$

0.10

 

$

(0.64

)

$

0.20

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares used in computation:

 

 

 

 

 

 

 

 

 

 

 

Basic

 

29,265

 

29,134

 

28,684

 

29,200

 

28,598

 

Diluted

 

29,503

 

29,134

 

29,268

 

29,200

 

29,174

 

 

2



 


(A)       Cost of sales in the quarter ended December 29, 2001 included a non-recurring favorable inventory adjustment of $1,599 ($657 after-tax and net of minority interest ($0.02 per diluted share)). Cost of sales in the quarter ended March 29, 2003 included an additional inventory reserve requirement of $2,743 ($1,220 after-tax and net of minority interest ($0.04 per diluted share)) due to lower forecasted outlook in Lambda Physik’s lithography business.

 

(B)     Goodwill impairment charges in the quarter ended March 29, 2003 were $2,358 ($1,769 net of minority interest ($0.06 per diluted share)).

 

(C)       Restructuring and other charges in the quarter ended December 29, 2002 include a $10,960 after-tax ($0.37 per diluted share) restructuring and impairment charge primarily related to the previously communicated termination of activities in the Telecom Actives Group and a $2,306 after-tax ($0.08 per diluted share) allowance against a note receivable.

 

(D)       Other income (expense) for the quarter ended December 28, 2002 includes an impairment charge on the Lumenis shares held by Coherent of $10,212 ($10,212 after-tax ($0.35 per diluted share)).

 

(E)         Other income for the March 30, 2002 quarter end and fiscal year-to-date includes a gain on sale of real estate of $1,665 ($1,000  after-tax ($0.03 per diluted share)).

 

(F)         The March 29, 2003 quarter end includes a $4,400 ($1,953 after-tax and net of minority interest ($0.07 per diluted share)) settlement fee related to the cancellation of a customer contract received by Lambda Physik.

 

Summarized balance sheet information is as follows (unaudited, in thousands):

 

 

 

Mar. 29,
2003

 

Sept. 28,
2002 (A)

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS:

 

 

 

 

 

Cash and short-term investments

 

$

237,529

 

$

243,881

 

Other short-term equity investments

 

7,121

 

21,077

 

Accounts receivable, net

 

83,831

 

76,478

 

Inventories

 

94,960

 

89,218

 

Prepaid expenses and other assets

 

103,683

 

95,169

 

TOTAL CURRENT ASSETS

 

527,124

 

525,823

 

 

 

 

 

 

 

PROPERTY AND EQUIPMENT, NET

 

155,848

 

172,001

 

OTHER ASSETS

 

111,454

 

106,433

 

TOTAL ASSETS

 

$

794,426

 

$

804,257

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

Short-term borrowings

 

$

221

 

$

14,811

 

Current portion of long-term obligations

 

7,429

 

14,887

 

Accounts payable

 

15,817

 

13,757

 

Other current liabilities

 

62,700

 

54,752

 

TOTAL CURRENT LIABILITIES

 

86,167

 

98,207

 

 

 

 

 

 

 

LONG-TERM OBLIGATIONS

 

43,308

 

43,345

 

OTHER LONG-TERM LIABILITIES

 

114,031

 

105,462

 

 

 

 

 

 

 

TOTAL STOCKHOLDERS’ EQUITY

 

550,920

 

557,243

 

 

 

 

 

 

 

TOTAL LIABILITIES AND STOCKHOLDER’S EQUITY

 

$

794,426

 

$

804,257

 

 


(A) Derived from audited financial statements for the year ended September 28, 2002.

 

3



 

Reconciliation of GAAP to Non-GAAP summarized statement of operations (unaudited, in thousands, after-tax and net of minority interest):

 

 

 

Three Months Ended

 

Six Months Ended

 

 

 

Mar. 29,
2003

 

Dec. 28,
2002

 

Mar. 30,
2002

 

Mar. 29,
2003

 

Mar. 30,
2002

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP net income (loss)

 

$

1,927

 

$

(20,483

)

$

3,007

 

$

(18,556

)

$

5,737

 

Gain on contract settlements (1)

 

(1,953

)

 

 

 

 

(1,953

)

 

 

Goodwill impairment (2)

 

1,769

 

 

 

 

 

1,769

 

 

 

Restructuring and other charges

 

 

 

13,266

 

 

 

13,266

 

 

 

Write-down of Lumenis investment

 

 

 

10,212

 

 

 

10,212

 

 

 

Gain on sale of real estate

 

 

 

 

 

(1,000

)

 

 

(1,000

)

Inventory adjustment (3)

 

 

 

 

 

 

 

 

 

(657

)

Non-GAAP net income

 

$

1,743

 

$

2,995

 

$

2,007

 

$

4,738

 

$

4,080

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-GAAP net income per share

 

$

0.06

 

$

0.10

 

$

0.07

 

$

0.16

 

$

0.14

 

 


(1)     Net of minority interest of $(1,015)

(2)     Net of minority interest of $589

(3)     Net of minority interest of $(382)

 

The statements in this press release that relate to future plans, events or performance, including statements such as suggesting that Coherent’s recent orders combined with the acquisition of Positive Light, Inc. should enable Coherent to achieve modest revenue growth during the second half of the fiscal year are forward-looking statements.  Factors that could cause actual results to differ materially include risks and uncertainties, including risks associated to currency adjustments, contract cancellations, manufacturing risks, competitive factors, and uncertainties pertaining to customer orders, demand for products and services, any effects from the recent outbreaks of severe acute respiratory syndrome or SARS, the hostilities in the Middle East, and development of markets for the Company’s products and services and other risks identified in the Company’s SEC filings.  Actual results, events and performance may differ materially.  Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.  The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

 

Readers are encouraged to refer to the risk disclosures described in the Company’s reports on Forms 10-K, 10-Q and 8K, as applicable.

 

Founded in 1966, Coherent, Inc. is a Standard & Poor’s SmallCap 600 company and a world leader in providing photonics based solutions to the commercial and scientific research markets. Please direct any questions to Leen Simonet, Chief Financial Officer at 408-764-4161. For more information about Coherent, visit the Company’s Web site at www.coherentinc.com for product and financial updates.

 

 

5100 Patrick Henry Dr. . P. O. Box 54980, Santa Clara, California  95056—0980 . Telephone (408) 764-4000

 

4